Home / Resources and Insights / New Enzyme Fermentation Plant in Changshu, China
New Enzyme Fermentation Plant in Changshu, China
Less than 1 min read time
We’re excited to announce the latest enhancement to our Early Intermediates manufacturing facility in Changshu, China: a new enzyme fermentation...

We’re excited to announce the latest enhancement to our Early Intermediates manufacturing facility in Changshu, China: a new enzyme fermentation plant that strengthens our biocatalysis capabilities. This expansion increases our total enzyme fermentation capacity to 22,850 L, allowing us to better meet your project’s unique needs by offering greater scalability, speed, and efficiency.
WuXi STA’s Biocatalysis Technology Platform provides comprehensive solutions, from enzyme screening, enzyme evolution and enzyme production to biocatalytic process development and production. With over 2,500 library enzymes and expertise in 25+ reaction types, we’re here to ensure your projects move forward with confidence and success. In 2023, we applied biocatalysis across 60 synthetic steps, producing over 90 metric tons of APIs and intermediates, helping our partners bring treatments to market faster and more sustainably.
Related Reading
WuXi STA Forms Strategic Partnership with Beta Pharma
STA will Accelerate Process R&D and Manufacturing of Late Phase and Commercial Targets STA Pharmaceutical Co., Ltd., (WuXi STA) –...
New Blow-Fill-Seal Aseptic Filling Line
New Capability Spotlight: We just launched a new Blow-Fill-Seal (BFS) aseptic filling line at our drug product site in Wuxi...
WuXi STA launched a new PSD-4 spray dryer at our Taixing API manufacturing facility in China
WuXi STA continues to expand spray-dried dispersion (SDD) capabilities with the launch of a new PSD-4 spray dryer at our Taixing API...